Furthermore, the treatment of pancreatic cancer cells with recombinant CXCL14 did not increase cell proliferation nor did CXCL14 protect against gemcitabine-induced apoptosis when cells were treated with the IC50 concentration of gemcitabine in vitro [115]. The gene discussed is CXCL14; the disease is pancreatic neoplasm.